Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.
- DOI
- 10.1002/jcph.6187
- Published
- 2025 Jun
- Container
- Journal of clinical pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jcph.6187,
title = {Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.},
author = {Hayato S and Hamuro L and Shimizu T and Yonemori K and Nishio S and Yunokawa M and Yoshida T and Nishio M and Matsumoto K and Takehara K and Hasegawa K and Kozuki T and Hirashima Y and Kato H and Miura T and Nomoto M and Zhao Y and Zhu L and Yasuda S},
year = {2025},
journal = {Journal of clinical pharmacology},
doi = {10.1002/jcph.6187},
url = {https://doi.org/10.1002/jcph.6187}
}RIS
TY - JOUR TI - Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors. AU - Hayato S AU - Hamuro L AU - Shimizu T AU - Yonemori K AU - Nishio S AU - Yunokawa M AU - Yoshida T AU - Nishio M AU - Matsumoto K AU - Takehara K AU - Hasegawa K AU - Kozuki T AU - Hirashima Y AU - Kato H AU - Miura T AU - Nomoto M AU - Zhao Y AU - Zhu L AU - Yasuda S PY - 2025 JO - Journal of clinical pharmacology DO - 10.1002/jcph.6187 UR - https://doi.org/10.1002/jcph.6187 ER -
APA
S, H., L, H., T, S., K, Y., S, N., M, Y., T, Y., M, N., K, M., K, T., K, H., T, K., Y, H., H, K., T, M., M, N., Y, Z., L, Z., & S, Y. (2025). Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.. Journal of clinical pharmacology. https://doi.org/10.1002/jcph.6187
Source records
- pubmed · retrieved 2026-09-25T14:29:13.797Z